Influence of pyruvate on economy of contraction in isolated rabbit myocardium
Background Treatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which combines a favourable haemodynamic profile with low expenditure for energy metabolism. Pyruvate exhibits positive inotropic effects in vitro and...
Saved in:
Published in: | European journal of heart failure Vol. 9; no. 8; pp. 754 - 761 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Blackwell Publishing Ltd
01-08-2007
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background
Treatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which combines a favourable haemodynamic profile with low expenditure for energy metabolism. Pyruvate exhibits positive inotropic effects in vitro and in patients with heart failure. The effect on myocardial energy metabolism however remains unclear, but is meaningful in light of a clinical application.
Aims and methods
We investigated the influence of pyruvate on contractility and oxygen consumption in isolated isometric contracting rabbit myocardium compared to β-adrenergic stimulation with isoproterenol.
Results
Pyruvate (30 mM) increased developed force from 18.7±4.1 to 50.8±12.1 mN/mm2 (n=10, p<0.01). Force-time integral (FTI) increased by 329%, oxygen consumption assessed by diffusion-microelectrode technique increased from 2.86±0.30 mlO2/min*100 g to 6.28±1.28 mlO2/min*100 g (n=7, p<0.05). Economy of myocardial contraction calculated as the ratio of total FTI to oxygen consumption remained unchanged. In contrast, while isoproterenol (10 μM) produced a comparable increase in developed force from 21.4±8.3 to 67.3±15mN/mm2 (n=7, p<0.01), FTI increased only by 260% and MVO2 increased from 2.96±0.43 to 6.12±1.01 mlO2/min*100 g (n=7, p<0.01); thus, economy decreased by 23% (n=7, p<0.05).
Conclusion
Pyruvate does not impair economy of myocardial contraction while isoproterenol decreases economy. Regarding energy expenditure, pyruvate appears superior to isoproterenol for the purpose of positive inotropic stimulation. |
---|---|
AbstractList | Background
Treatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which combines a favourable haemodynamic profile with low expenditure for energy metabolism. Pyruvate exhibits positive inotropic effects in vitro and in patients with heart failure. The effect on myocardial energy metabolism however remains unclear, but is meaningful in light of a clinical application.
Aims and methods
We investigated the influence of pyruvate on contractility and oxygen consumption in isolated isometric contracting rabbit myocardium compared to β-adrenergic stimulation with isoproterenol.
Results
Pyruvate (30 mM) increased developed force from 18.7±4.1 to 50.8±12.1 mN/mm2 (n=10, p<0.01). Force-time integral (FTI) increased by 329%, oxygen consumption assessed by diffusion-microelectrode technique increased from 2.86±0.30 mlO2/min*100 g to 6.28±1.28 mlO2/min*100 g (n=7, p<0.05). Economy of myocardial contraction calculated as the ratio of total FTI to oxygen consumption remained unchanged. In contrast, while isoproterenol (10 μM) produced a comparable increase in developed force from 21.4±8.3 to 67.3±15mN/mm2 (n=7, p<0.01), FTI increased only by 260% and MVO2 increased from 2.96±0.43 to 6.12±1.01 mlO2/min*100 g (n=7, p<0.01); thus, economy decreased by 23% (n=7, p<0.05).
Conclusion
Pyruvate does not impair economy of myocardial contraction while isoproterenol decreases economy. Regarding energy expenditure, pyruvate appears superior to isoproterenol for the purpose of positive inotropic stimulation. BACKGROUNDTreatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which combines a favourable haemodynamic profile with low expenditure for energy metabolism. Pyruvate exhibits positive inotropic effects in vitro and in patients with heart failure. The effect on myocardial energy metabolism however remains unclear, but is meaningful in light of a clinical application.AIMS AND METHODSWe investigated the influence of pyruvate on contractility and oxygen consumption in isolated isometric contracting rabbit myocardium compared to beta-adrenergic stimulation with isoproterenol.RESULTSPyruvate (30 mM) increased developed force from 18.7+/-4.1 to 50.8+/-12.1 mN/mm2 (n=10, p<0.01). Force-time integral (FTI) increased by 329%, oxygen consumption assessed by diffusion-microelectrode technique increased from 2.86+/-0.30 mlO2/min*100 g to 6.28+/-1.28 mlO2/min*100 g (n=7, p<0.05). Economy of myocardial contraction calculated as the ratio of total FTI to oxygen consumption remained unchanged. In contrast, while isoproterenol (10 microM) produced a comparable increase in developed force from 21.4+/-8.3 to 67.3+/-15 mN/mm2 (n=7, p<0.01), FTI increased only by 260% and MVO2 increased from 2.96+/-0.43 to 6.12+/-1.01 mlO2/min*100 g (n=7, p<0.01); thus, economy decreased by 23% (n=7, p<0.05).CONCLUSIONPyruvate does not impair economy of myocardial contraction while isoproterenol decreases economy. Regarding energy expenditure, pyruvate appears superior to isoproterenol for the purpose of positive inotropic stimulation. Treatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which combines a favourable haemodynamic profile with low expenditure for energy metabolism. Pyruvate exhibits positive inotropic effects in vitro and in patients with heart failure. The effect on myocardial energy metabolism however remains unclear, but is meaningful in light of a clinical application. We investigated the influence of pyruvate on contractility and oxygen consumption in isolated isometric contracting rabbit myocardium compared to beta-adrenergic stimulation with isoproterenol. Pyruvate (30 mM) increased developed force from 18.7+/-4.1 to 50.8+/-12.1 mN/mm2 (n=10, p<0.01). Force-time integral (FTI) increased by 329%, oxygen consumption assessed by diffusion-microelectrode technique increased from 2.86+/-0.30 mlO2/min*100 g to 6.28+/-1.28 mlO2/min*100 g (n=7, p<0.05). Economy of myocardial contraction calculated as the ratio of total FTI to oxygen consumption remained unchanged. In contrast, while isoproterenol (10 microM) produced a comparable increase in developed force from 21.4+/-8.3 to 67.3+/-15 mN/mm2 (n=7, p<0.01), FTI increased only by 260% and MVO2 increased from 2.96+/-0.43 to 6.12+/-1.01 mlO2/min*100 g (n=7, p<0.01); thus, economy decreased by 23% (n=7, p<0.05). Pyruvate does not impair economy of myocardial contraction while isoproterenol decreases economy. Regarding energy expenditure, pyruvate appears superior to isoproterenol for the purpose of positive inotropic stimulation. |
Author | Hermann, Hans-Peter Keweloh, Boris Datz, Nicolin Zeitz, Oliver Janssen, Paul M.L. Siegel, Ulf |
Author_xml | – sequence: 1 givenname: Boris surname: Keweloh fullname: Keweloh, Boris organization: Franz-Volhard-Klinik, Universitätsklinikum Charité, Berlin, Germany – sequence: 2 givenname: Paul M.L. surname: Janssen fullname: Janssen, Paul M.L. organization: Abteilung Kardiologie und Pneumologie, Universität Göttingen, Göttingen, Germany – sequence: 3 givenname: Ulf surname: Siegel fullname: Siegel, Ulf organization: Abteilung Kardiologie und Pneumologie, Universität Göttingen, Göttingen, Germany – sequence: 4 givenname: Nicolin surname: Datz fullname: Datz, Nicolin organization: Abteilung Kardiologie und Pneumologie, Universität Göttingen, Göttingen, Germany – sequence: 5 givenname: Oliver surname: Zeitz fullname: Zeitz, Oliver organization: Abteilung Kardiologie und Pneumologie, Universität Göttingen, Göttingen, Germany – sequence: 6 givenname: Hans-Peter surname: Hermann fullname: Hermann, Hans-Peter email: phermann@med.uni-goettingen.de organization: Abteilung Kardiologie und Pneumologie, Universität Göttingen, Göttingen, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17532261$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkE9r3DAQxUVJaP60H6HBp97sjCTbko_JkmQTkhRKSo9ClsbEG9vaSnZbf_tq8dKQW0Cgx_B7b4Z3Qg4GNyAhXyhkFGh5vslw84zajxkDEBnwDCj9QI6pFFUKMs8PouZSppXM2RE5CWEDQAUA-0iOqCg4YyU9Jg-3Q9NNOBhMXJNsZz_91mPUQ4LGDa6fd-OoRq_N2MZxG19wXYRs4nVdt2PSz85ob9up_0QOG90F_Lz_T8mP66un1Tq9_3Zzu7q4T01eMZrWBgFNzlHwwjLJmG3AQtMI0CYSBUVJaw6VRURe5aa2RpQoUQiLTa4FPyVfl9ytd78mDKPq22Cw6_SAbgqqlLRkOezAYgGNdyF4bNTWt732s6Kgdj2qjdr3qHY9KuAq9hh9Z_sFU92jfXXti4vA5QL8aTuc35eqru7W12-3wBLipu27D0sXSxtG_PvfpP2LKgUXhfr5eKOe2OXjSn5fqxX_Bz_Sp4o |
CitedBy_id | crossref_primary_10_1139_y2012_129 crossref_primary_10_1139_cjpp_2013_0473 crossref_primary_10_1007_s00392_010_0261_4 crossref_primary_10_1016_j_etap_2019_103206 crossref_primary_10_1371_journal_pone_0063608 |
Cites_doi | 10.1016/j.ejheart.2003.10.001 10.1152/ajplegacy.1957.192.1.148 10.1161/01.CIR.82.3.774 10.1016/0167-4889(94)90109-0 10.1152/ajpheart.1998.274.5.H1481 10.1006/jmcc.2002.1527 10.1161/01.RES.46.5.703 10.1152/ajpheart.2000.279.2.H702 10.1097/00003246-199405000-00022 10.1177/153537020523000701 10.1161/01.RES.73.5.813 10.1113/jphysiol.2003.040345 10.1080/713773607 10.1007/BF00583798 10.1006/jmcc.1998.0706 10.1056/NEJM198601303140506 10.1111/j.1432-1033.1989.tb14637.x 10.1152/ajpheart.1997.273.5.H2415 10.1016/S0140-6736(98)06423-X 10.1152/ajpheart.1998.274.1.H8 10.1006/jmcc.1994.1173 10.1097/00000658-198905000-00016 10.1016/S0021-9258(18)47519-9 10.1161/01.RES.64.1.104 10.1161/01.CIR.80.1.51 10.1042/bj2690827 10.1161/01.CIR.94.12.3155 10.1152/ajplegacy.1966.210.2.351 10.1136/hrt.76.3.223 10.1152/ajpheart.1995.268.1.H82 10.1038/217078a0 10.1161/01.RES.43.2.189 10.1161/01.RES.62.2.247 10.1056/NEJM198602063140605 10.1161/01.RES.65.5.1441 10.1016/S0008-6363(01)00437-0 10.1161/hc0202.102238 10.1152/physrev.1990.70.2.247 |
ContentType | Journal Article |
Copyright | 2007 European Society of Cardiology 2007 Published on behalf of the European Society of Cardiology. All rights reserved. © 2007 the Authors |
Copyright_xml | – notice: 2007 European Society of Cardiology 2007 – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © 2007 the Authors |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ejheart.2007.03.011 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-0844 |
EndPage | 761 |
ExternalDocumentID | 10_1016_j_ejheart_2007_03_011 17532261 EJHF2007-03-011 10.1016/j.ejheart.2007.03.011 ark_67375_WNG_T2BNC8RH_C |
Genre | article Journal Article |
GroupedDBID | --- --K .I3 0R~ 1B1 1OC 1~5 24P 29G 2WC 33P 4G. 53G 5GY 5VS 6PF 7-5 70D AAESR AAHHS AANLZ AAPNW AASGY AAWTL AAXRX AAZKR ABCUV ABDBF ABJNI ABKDP ABLJU ABQWH ABXGK ABZBJ ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADEYI ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFPWT AGKEF AHBTC AIACR AIJHB AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BHBCM BMXJE BRXPI BSCLL C45 CKLRP CS3 CZ4 DCZOG DRFUL DRMAN DRSTM DU5 E3Z EBD EBS EJD EMOBN ESX F5P FEDTE FUBAC G-S GODZA H13 HGLYW HVGLF HZ~ IHE IPNFZ KBYEO LATKE LEEKS LITHE LOXES LUTES LYRES M41 M49 MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NQ- NU- O0~ O66 O9- OK1 OVD O~Y P2P P2W Q1. RD5 RIG ROL RPZ RXO SDG SEL SEW SUPJJ SV3 TEORI TUS UHS V9Y W8F WBKPD WHWMO WIH WIJ WIK WIN WOHZO WVDHM WXSBR WYJ X7H ~91 CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4921-bce0ec43e735d2822df0d0ff70acc4951e81b309deee394cbdc76e8e77def4a73 |
IEDL.DBID | 33P |
ISSN | 1388-9842 |
IngestDate | Fri Oct 25 01:30:53 EDT 2024 Fri Nov 22 00:43:18 EST 2024 Sat Sep 28 07:47:26 EDT 2024 Sat Aug 24 01:03:28 EDT 2024 Wed Aug 28 03:26:20 EDT 2024 Wed Oct 30 09:53:49 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Heart failure Energetics Pyruvate Oxygen consumption Inotropic therapy |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4921-bce0ec43e735d2822df0d0ff70acc4951e81b309deee394cbdc76e8e77def4a73 |
Notes | ark:/67375/WNG-T2BNC8RH-C ArticleID:EJHF2007-03-011 istex:DB3380C0C3651773AB71CD4E597BD926B09A7AAB ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.ejheart.2007.03.011 |
PMID | 17532261 |
PQID | 68162407 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_68162407 crossref_primary_10_1016_j_ejheart_2007_03_011 pubmed_primary_17532261 wiley_primary_10_1016_j_ejheart_2007_03_011_EJHF2007_03_011 oup_primary_10_1016_j_ejheart_2007_03_011 istex_primary_ark_67375_WNG_T2BNC8RH_C |
PublicationCentury | 2000 |
PublicationDate | 2007-08 20070800 August 2007 2007-Aug 2007-08-00 20070801 |
PublicationDateYYYYMMDD | 2007-08-01 |
PublicationDate_xml | – month: 08 year: 2007 text: 2007-08 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | European journal of heart failure |
PublicationTitleAlternate | European Journal of Heart Failure |
PublicationYear | 2007 |
Publisher | Blackwell Publishing Ltd Elsevier |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Elsevier |
References | Mallet R.T. Bünger R. Energetic modulation of cardiac inotropism and sarcoplasmic reticular Ca2+ uptake Biochim Biophys Acta 1994 1224 22 32 ter Keurs H.E. Rijnsburger W.H. van Heuningen R. Nagelsmit M.J. Tension development and sarcomere length in rat cardiac trabeculae: evidence of length-dependent activation Circ Res 1980 46 703 714 Laughlin M.R. Heineman F.W. The relationship between phosphorylation potential and redox state in the isolated working rabbit heart J Mol Cell Cardiol 1994 26 1525 1536 Sarnoff S.J. Braunwald E. Welch G.H. Case R.B. Stainsby W.N. Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index Am J Physiol 1958 192 148 156 Bünger R. Mallet R.T. Hartman A. Pyruvate enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure Eur J Biochem 1988 180 221 233 Hermann H.P. Zeitz O. Keweloh B. Hasenfuss G. Janssen P.M.L. Pyruvate potentiates inotropic effects of isoproterenol and Ca(2+) in rabbit cardiac muscle preparations Am J Physiol (Heart Circ Physiol) 2000 279 2 H702 H708 Yanos J. Patti M.J. Stanko R.T. Hemodynamic effects of intravenous pyruvate in the intact, anesthetized dog Crit Care Med 1994 22 844 850 Maier L.S. Braunhalter J. Horn W. Weichert S. Pieske B. The role of SR Ca(2+)-content in blunted inotropic responsiveness of failing human myocardium J Mol Cell Cardiol 2002 34 455 467 Hasenfuss G. Maier L.S. Hermann H.P. et al. Influence of pyruvate on contractile performance and Ca2+-cycling in isolated failing human myocardium Circulation 2002 105 194 199 Rapundalo S.T. Solaro R.J. Kranias E.G. Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins Circ Res 1989 64 104 111 Liedtke A.J. Nellis S.H. Effects of buffered pyruvate on regional cardiac function in moderate, short-term ischemia in swine heart Circ Res 1978 43 189 199 Mentzer R.M. Jr. van Whylen D.G. Sodhi J. et al. Effect of pyruvate on regional ventricular function in normal and stunned myocardium Ann Surg 1989 209 629 633 Janssen P.M.L. Lehnart S.E. Prestle J. et al. The trabecula culture system: a novel technique to study contractile parameters over a multiday time period Am J Physiol (Heart Circ Physiol) 1998 274 H1481 H1488 Scholz T.D. Laughlin M.R. Balaban R.S. Kupriyanov V.V. Heineman F.W. Effect of substrate on mitochondrial NADH, cytosolic redox state, and phosphorylated compounds in isolated hearts Am J Physiol (Heart Circ Physiol) 1995 268 H82 H91 Uretsky B.F. Jessup M. Konstam M.A. et al. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group Circulation 1990 82 774 780 Zweier J.L. Jacobus W.E. Substrate induced alterations of high energy phosphate metabolism and contractile function in the perfused heart J Biol Chem 1987 262 8015 8021 Colucci W.S. Wright R.F. Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent developments (first of two parts) New Engl J Med 1986 314 290 299 Hasenfuss G. Mulieri L.A. Allen P.D. Just H. Alpert N.R. Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium Circulation 1996 94 3155 3160 Martin B.J. Valdivia H.H. Bünger R. Lasley R.D. Mentzer R.M. Jr. Pyruvate augments calcium transients and cell shortening in rat ventricular myocytes Am J Physiol (Heart Circ Physiol) 1998 274 1 Pt 2 H8 H17 Hermann H.P. Pieske B. Schwarzmuller E. Keul J. Just H. Hasenfuss G. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study Lancet 1999 353 1321 1323 Meyer M. Keweloh B. Güth K. et al. Frequency-dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations J Mol Cell Cardiol 1998 30 1459 1470 Challoner D.R. Respiration in myocardium Nature 1968 217 78 79 Zima A.V. Kockskämper J. Mejia-Alvarez R. Blatter L.A. Pyruvate modulates cardiac sarcoplasmic reticulum Ca2+ release in rats via mitochondria-dependent and -independent mechanisms J Physiol 2003 550 765 783 Hermann H.P. Zeitz O. Lehnart S.E. et al. Potentition of β-adrenergic inotropic response by pyruvate in failing human myocardium Cardiovasc Res 2002 53 116 123 Poole R.C. Cranmer S.L. Halestrap A.P. Levi A.J. Substrate and inhibitor specificity of monocarboxylate transport into heart cells and erythrocytes. Further evidence for the existence of two distinct carriers Biochem J 1990 269 827 829 Kurihara S. Konishi M. Effects of beta-adrenoceptor stimulation on intracellular Ca transients and tension in rat ventricular muscle Pflügers Arch 1987 409 427 437 Hasenfuss G. Holubarsch C. Heiss H.W. et al. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone Circulation 1989 80 51 64 Mallet R.T. Sun J. Knott E.M. Sharma A.B. Olivencia-Yurvati A.H. Metabolic cardioprotection by pyruvate: recent progress Exp Biol Med 2005 230 435 443 Janssen P.M.L. de Tombe P.P. Protein kinase A does not alter unloaded velocity of sarcomere shortening in skinned rat cardiac trabeculae Am J Physiol (Heart Circ Physiol) 1997 273 H2415 H2422 Mc Donald R.H. Jr. Developed tension: a major determinant of myocardial oxygen consumption Am J Physiol 1966 210 351 356 Baudet S. Shaoulian R. Bers D.M. Effects of thapsigargin and cyclopiazonic acid on twitch force and sarcoplasmic reticulum Ca2+ content of rabbit ventricular muscle Circ Res 1993 73 813 819 Colucci W.S. Wright R.F. Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent developments (second of two parts) New Engl J Med 1986 314 349 358 Suga H. Ventricular energetics Physiol Rev 1990 70 247 277 Mulieri L.A. Hasenfuss G. Ittleman F. Blanchard E.M. Alpert N.R. Protection of human left ventricular myocardium from cutting injury with 2,3 butanedione monoxime Circ Res 1989 65 1441 1449 Hermann H.P. Arp J. Pieske B. et al. Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure Eur J Heart Fail 2004 6 213 218 De Boer R.A. Pinto Y.M. Van Veldhuisen D.J. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities Microcirculation 2003 10 113 126 Lubsen J. Just H. Hjalmarsson A.C. et al. Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial Heart 1996 76 223 231 Endoh M. Blinks J.R. Actions of sympathomimetic amines on the Ca2+ transients and contractions of rabbit myocardium: reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through alpha- and beta-adrenoceptors Circ Res 1988 62 247 265 1987; 262 1966; 210 1986; 314 1989; 64 2005; 230 1989; 65 1990; 269 2000; 279 2002; 53 1997; 273 1989; 80 2002; 34 1980; 46 1996; 94 1994; 22 1994; 1224 2004; 6 1987; 409 1994; 26 1992 1996; 76 2003; 10 2003; 550 1990; 82 1998; 274 1989; 209 1968; 217 1993; 73 1978; 43 1988; 180 2002; 105 1995; 268 1988; 62 1999; 353 1998; 30 1990; 70 1958; 192 e_1_2_5_27_1 e_1_2_5_28_1 e_1_2_5_26_1 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_29_1 Martin B.J. (e_1_2_5_19_1) 1998; 274 e_1_2_5_20_1 e_1_2_5_40_1 Zweier J.L. (e_1_2_5_16_1) 1987; 262 e_1_2_5_15_1 e_1_2_5_38_1 e_1_2_5_14_1 e_1_2_5_39_1 e_1_2_5_17_1 Scholz T.D. (e_1_2_5_22_1) 1995; 268 e_1_2_5_36_1 e_1_2_5_9_1 e_1_2_5_37_1 e_1_2_5_8_1 e_1_2_5_11_1 Janssen P.M.L. (e_1_2_5_25_1) 1998; 274 e_1_2_5_34_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_32_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_18_1 Alpert N.R. (e_1_2_5_33_1) 1992 Mc Donald R.H. (e_1_2_5_31_1) 1966; 210 e_1_2_5_30_1 |
References_xml | – volume: 217 start-page: 78 year: 1968 end-page: 79 article-title: Respiration in myocardium publication-title: Nature – volume: 209 start-page: 629 year: 1989 end-page: 633 article-title: Effect of pyruvate on regional ventricular function in normal and stunned myocardium publication-title: Ann Surg – volume: 43 start-page: 189 year: 1978 end-page: 199 article-title: Effects of buffered pyruvate on regional cardiac function in moderate, short‐term ischemia in swine heart publication-title: Circ Res – volume: 1224 start-page: 22 year: 1994 end-page: 32 article-title: Energetic modulation of cardiac inotropism and sarcoplasmic reticular Ca uptake publication-title: Biochim Biophys Acta – volume: 230 start-page: 435 year: 2005 end-page: 443 article-title: Metabolic cardioprotection by pyruvate: recent progress publication-title: Exp Biol Med – volume: 105 start-page: 194 year: 2002 end-page: 199 article-title: Influence of pyruvate on contractile performance and Ca2+‐cycling in isolated failing human myocardium publication-title: Circulation – volume: 314 start-page: 290 year: 1986 end-page: 299 article-title: New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent developments (first of two parts) publication-title: New Engl J Med – volume: 210 start-page: 351 year: 1966 end-page: 356 article-title: Developed tension: a major determinant of myocardial oxygen consumption publication-title: Am J Physiol – volume: 70 start-page: 247 year: 1990 end-page: 277 article-title: Ventricular energetics publication-title: Physiol Rev – volume: 279 start-page: H702 issue: 2 year: 2000 end-page: H708 article-title: Pyruvate potentiates inotropic effects of isoproterenol and Ca in rabbit cardiac muscle preparations publication-title: Am J Physiol (Heart Circ Physiol) – volume: 34 start-page: 455 year: 2002 end-page: 467 article-title: The role of SR Ca ‐content in blunted inotropic responsiveness of failing human myocardium publication-title: J Mol Cell Cardiol – volume: 409 start-page: 427 year: 1987 end-page: 437 article-title: Effects of beta‐adrenoceptor stimulation on intracellular Ca transients and tension in rat ventricular muscle publication-title: Pflügers Arch – volume: 30 start-page: 1459 year: 1998 end-page: 1470 article-title: Frequency‐dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations publication-title: J Mol Cell Cardiol – volume: 273 start-page: H2415 year: 1997 end-page: H2422 article-title: Protein kinase A does not alter unloaded velocity of sarcomere shortening in skinned rat cardiac trabeculae publication-title: Am J Physiol (Heart Circ Physiol) – volume: 180 start-page: 221 year: 1988 end-page: 233 article-title: Pyruvate enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near‐complete prevention of reperfusion contractile failure publication-title: Eur J Biochem – start-page: 111 year: 1992 end-page: 128 article-title: Myocardial chemo‐mechanical energy transduction – volume: 80 start-page: 51 year: 1989 end-page: 64 article-title: Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone publication-title: Circulation – volume: 353 start-page: 1321 year: 1999 end-page: 1323 article-title: Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study publication-title: Lancet – volume: 550 start-page: 765 year: 2003 end-page: 783 article-title: Pyruvate modulates cardiac sarcoplasmic reticulum Ca release in rats via mitochondria‐dependent and ‐independent mechanisms publication-title: J Physiol – volume: 274 start-page: H1481 year: 1998 end-page: H1488 article-title: The trabecula culture system: a novel technique to study contractile parameters over a multiday time period publication-title: Am J Physiol (Heart Circ Physiol) – volume: 65 start-page: 1441 year: 1989 end-page: 1449 article-title: Protection of human left ventricular myocardium from cutting injury with 2,3 butanedione monoxime publication-title: Circ Res – volume: 73 start-page: 813 year: 1993 end-page: 819 article-title: Effects of thapsigargin and cyclopiazonic acid on twitch force and sarcoplasmic reticulum Ca content of rabbit ventricular muscle publication-title: Circ Res – volume: 82 start-page: 774 year: 1990 end-page: 780 article-title: Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group publication-title: Circulation – volume: 22 start-page: 844 year: 1994 end-page: 850 article-title: Hemodynamic effects of intravenous pyruvate in the intact, anesthetized dog publication-title: Crit Care Med – volume: 10 start-page: 113 year: 2003 end-page: 126 article-title: The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities publication-title: Microcirculation – volume: 64 start-page: 104 year: 1989 end-page: 111 article-title: Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins publication-title: Circ Res – volume: 76 start-page: 223 year: 1996 end-page: 231 article-title: Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial publication-title: Heart – volume: 26 start-page: 1525 year: 1994 end-page: 1536 article-title: The relationship between phosphorylation potential and redox state in the isolated working rabbit heart publication-title: J Mol Cell Cardiol – volume: 62 start-page: 247 year: 1988 end-page: 265 article-title: Actions of sympathomimetic amines on the Ca transients and contractions of rabbit myocardium: reciprocal changes in myofibrillar responsiveness to Ca mediated through alpha‐ and beta‐adrenoceptors publication-title: Circ Res – volume: 192 start-page: 148 year: 1958 end-page: 156 article-title: Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension‐time index publication-title: Am J Physiol – volume: 6 start-page: 213 year: 2004 end-page: 218 article-title: Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure publication-title: Eur J Heart Fail – volume: 46 start-page: 703 year: 1980 end-page: 714 article-title: Tension development and sarcomere length in rat cardiac trabeculae: evidence of length‐dependent activation publication-title: Circ Res – volume: 94 start-page: 3155 year: 1996 end-page: 3160 article-title: Influence of isoproterenol and ouabain on excitation‐contraction coupling, cross‐bridge function, and energetics in failing human myocardium publication-title: Circulation – volume: 314 start-page: 349 year: 1986 end-page: 358 article-title: New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent developments (second of two parts) publication-title: New Engl J Med – volume: 262 start-page: 8015 year: 1987 end-page: 8021 article-title: Substrate induced alterations of high energy phosphate metabolism and contractile function in the perfused heart publication-title: J Biol Chem – volume: 274 start-page: H8 issue: 1 Pt 2 year: 1998 end-page: H17 article-title: Pyruvate augments calcium transients and cell shortening in rat ventricular myocytes publication-title: Am J Physiol (Heart Circ Physiol) – volume: 268 start-page: H82 year: 1995 end-page: H91 article-title: Effect of substrate on mitochondrial NADH, cytosolic redox state, and phosphorylated compounds in isolated hearts publication-title: Am J Physiol (Heart Circ Physiol) – volume: 53 start-page: 116 year: 2002 end-page: 123 article-title: Potentition of β‐adrenergic inotropic response by pyruvate in failing human myocardium publication-title: Cardiovasc Res – volume: 269 start-page: 827 year: 1990 end-page: 829 article-title: Substrate and inhibitor specificity of monocarboxylate transport into heart cells and erythrocytes. Further evidence for the existence of two distinct carriers publication-title: Biochem J – ident: e_1_2_5_9_1 doi: 10.1016/j.ejheart.2003.10.001 – ident: e_1_2_5_32_1 doi: 10.1152/ajplegacy.1957.192.1.148 – ident: e_1_2_5_3_1 doi: 10.1161/01.CIR.82.3.774 – ident: e_1_2_5_18_1 doi: 10.1016/0167-4889(94)90109-0 – volume: 274 start-page: H1481 year: 1998 ident: e_1_2_5_25_1 article-title: The trabecula culture system: a novel technique to study contractile parameters over a multiday time period publication-title: Am J Physiol (Heart Circ Physiol) doi: 10.1152/ajpheart.1998.274.5.H1481 contributor: fullname: Janssen P.M.L. – ident: e_1_2_5_23_1 doi: 10.1006/jmcc.2002.1527 – ident: e_1_2_5_26_1 doi: 10.1161/01.RES.46.5.703 – ident: e_1_2_5_12_1 doi: 10.1152/ajpheart.2000.279.2.H702 – ident: e_1_2_5_15_1 doi: 10.1097/00003246-199405000-00022 – ident: e_1_2_5_17_1 doi: 10.1177/153537020523000701 – ident: e_1_2_5_34_1 doi: 10.1161/01.RES.73.5.813 – ident: e_1_2_5_36_1 doi: 10.1113/jphysiol.2003.040345 – ident: e_1_2_5_24_1 doi: 10.1080/713773607 – ident: e_1_2_5_38_1 doi: 10.1007/BF00583798 – ident: e_1_2_5_29_1 doi: 10.1006/jmcc.1998.0706 – start-page: 111 volume-title: The Heart and Cardiovascular System year: 1992 ident: e_1_2_5_33_1 contributor: fullname: Alpert N.R. – ident: e_1_2_5_6_1 doi: 10.1056/NEJM198601303140506 – ident: e_1_2_5_10_1 doi: 10.1111/j.1432-1033.1989.tb14637.x – ident: e_1_2_5_28_1 doi: 10.1152/ajpheart.1997.273.5.H2415 – ident: e_1_2_5_8_1 doi: 10.1016/S0140-6736(98)06423-X – volume: 274 start-page: H8 issue: 1 year: 1998 ident: e_1_2_5_19_1 article-title: Pyruvate augments calcium transients and cell shortening in rat ventricular myocytes publication-title: Am J Physiol (Heart Circ Physiol) doi: 10.1152/ajpheart.1998.274.1.H8 contributor: fullname: Martin B.J. – ident: e_1_2_5_21_1 doi: 10.1006/jmcc.1994.1173 – ident: e_1_2_5_14_1 doi: 10.1097/00000658-198905000-00016 – volume: 262 start-page: 8015 year: 1987 ident: e_1_2_5_16_1 article-title: Substrate induced alterations of high energy phosphate metabolism and contractile function in the perfused heart publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)47519-9 contributor: fullname: Zweier J.L. – ident: e_1_2_5_40_1 doi: 10.1161/01.RES.64.1.104 – ident: e_1_2_5_4_1 doi: 10.1161/01.CIR.80.1.51 – ident: e_1_2_5_35_1 doi: 10.1042/bj2690827 – ident: e_1_2_5_5_1 doi: 10.1161/01.CIR.94.12.3155 – volume: 210 start-page: 351 year: 1966 ident: e_1_2_5_31_1 article-title: Developed tension: a major determinant of myocardial oxygen consumption publication-title: Am J Physiol doi: 10.1152/ajplegacy.1966.210.2.351 contributor: fullname: Mc Donald R.H. – ident: e_1_2_5_2_1 doi: 10.1136/hrt.76.3.223 – volume: 268 start-page: H82 year: 1995 ident: e_1_2_5_22_1 article-title: Effect of substrate on mitochondrial NADH, cytosolic redox state, and phosphorylated compounds in isolated hearts publication-title: Am J Physiol (Heart Circ Physiol) doi: 10.1152/ajpheart.1995.268.1.H82 contributor: fullname: Scholz T.D. – ident: e_1_2_5_30_1 doi: 10.1038/217078a0 – ident: e_1_2_5_11_1 doi: 10.1161/01.RES.43.2.189 – ident: e_1_2_5_37_1 doi: 10.1161/01.RES.62.2.247 – ident: e_1_2_5_7_1 doi: 10.1056/NEJM198602063140605 – ident: e_1_2_5_27_1 doi: 10.1161/01.RES.65.5.1441 – ident: e_1_2_5_13_1 doi: 10.1016/S0008-6363(01)00437-0 – ident: e_1_2_5_20_1 doi: 10.1161/hc0202.102238 – ident: e_1_2_5_39_1 doi: 10.1152/physrev.1990.70.2.247 |
SSID | ssj0017002 |
Score | 1.8949339 |
Snippet | Background
Treatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which... Background Treatment of acute heart failure frequently requires positive‐inotropic stimulation. However, there is still no inotropic agent available, which... Treatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which combines a... BACKGROUNDTreatment of acute heart failure frequently requires positive-inotropic stimulation. However, there is still no inotropic agent available, which... |
SourceID | proquest crossref pubmed wiley oup istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 754 |
SubjectTerms | Animals Cardiotonic Agents - pharmacology Dose-Response Relationship, Drug energetics Energy Metabolism - drug effects Female heart failure In Vitro Techniques Indoles - pharmacology inotropic therapy Isoproterenol - pharmacology Myocardial Contraction - drug effects Myocardium - metabolism oxygen consumption Oxygen Consumption - drug effects pyruvate Pyruvic Acid - pharmacology Rabbits |
Title | Influence of pyruvate on economy of contraction in isolated rabbit myocardium |
URI | https://api.istex.fr/ark:/67375/WNG-T2BNC8RH-C/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.ejheart.2007.03.011 https://www.ncbi.nlm.nih.gov/pubmed/17532261 https://search.proquest.com/docview/68162407 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NT9swFLeASYjLYHx2Y8MHhLRDSlI7caKdoGspSFSID8HNcuwXiSJS1DZo_e_37CSlTDsggZRLomdHeR_x79nvg5D9CCGs7WblicCEHg8C46kkUl5s_CwJNQ8zZTfceleifxf_7tgyOSd1LkxZH2K24WYtw_2vrYGrdDznbw6aMLBNnydVHULW9F2OL3oMLpWDXcxOE4Rfxh4y1Iok5q2XTJ7D_87yao36ZNn955_8tzkY-hrVumWpu_phH7RGPlfIlB6VqvSFLEC-TpbPq7P3DXJ-WvczocOMPk1HxTPiVDrMKbjk5ql97CLfy1wJeo8XajYSGTpSaXo_oY9TXDpRJYvHTXLT7Vy3e17VjMHTPGkFXqrBB80ZCBYaG3tqMh_lmQlfaaQIA0AAzPzEAABLuE6NFhHEIISBjCvBtshSPsxhh1CWapYyHsWxQufQNmXB0WBaWRZGXMfQIM2a_fKprLkh62C0gayYZPtnCukziUxqkAMnpBm1Gj3YgDURytv-ibxuHffb8WVPthvkJ0rxrZPu1bKWaHL2HEXlMCzGErU7so5wg2yXKvAyITp_iGdx7C8n6be9SXbOet25-6_vGv2NrJT7zzZIcZcsTUYFfCeLY1P8cFbxF4HdDU8 |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfGJgEvMD7GChvzA0LiIV1SO3EinqBryWCtEBSxN8uxL9I6LZ26BtH_nrt8dN3EwySQ8pLIdpS738V35_tg7E2EKix1s_JU4EJPBoHzTBIZL3Z-noRWhrkhh1v6XY1P46MBlclJ21yYuj7EyuFGklH9r0nAySG9ZnBOuzClrs-LphCh6PqU5LslIwQlJXOIr6vzBOXX0YcCcZHEsnedy3P412Vu7FJbRPDftzLg1hTRm3pttTENH_-_T9pmjxrllH-o0fSEbUDxlN0fNcfvz9jouG1pwmc5v1zOy1-oqvJZwaHKb17S4yr4vU6X4Gd4IbhxkONzk2VnC36xxN0TUVlePGc_hoNJP_WafgyelUkv8DILPlgpQInQUfipy31kaa58Y3FEGADqwMJPHACIRNrMWRVBDEo5yKVRYodtFrMCdhkXmRWZkFEcG7QPqS8LzgbXy_MwkjaGDuu29NeXddkN3cajTXVDJGqhqbQvNBKpw95WXFqNNvNzillTof45_qQnvY_jfvwt1f0Oe4dsvOuiBy2zNUodHaWYAmbllUaAR2QLd9iLGgPXC6L9hyotzn1fsfpub9KDz-lw7f7lP80-YA_SyehEnxyPv7xiD2t3NMUs7rHNxbyEfXbvypWvKxH5A4F6EXc |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFD6CTZp4YVxHYRc_ICQeUpLaiRPxNLp2HbBqgiF4sxz7WFrR0qprJvrvOc6l6xAPk0DKS6JjRzmX-Dv2uQC8TgjC-m5WgYxsHIgosoHOEh2kNnRZbETstN9wG32V4x_p0cCXyTluc2Hq-hCrDTdvGdX_2hv4zLo1f3PSxYlv-rxo6hDybuhzfDcFQXJfRJ_zs9Vxggzr4ENOapGloneTyvPur9PcWqQ2Pb9__ZEAt4ZDb8Paal0abv-3L3oEDxtoyg5rXXoM97B4AlunzeH7Uzg9aRuasKljs-W8vCagyqYFwyq7eekfV6HvdbIEu6CLVJuILJvrPL9YsMslrZ2kk-XlM_g2HJz3R0HTjSEwIutFQW4wRCM4Sh5bH3xqXUgCdTLUhijiCAkB8zCziMgzYXJrZIIpSmnRCS35c9gopgW-AMZzw3MukjTV5B36riw0Gm3PuTgRJsUOdFv2q1lddEO10WgT1TDJN9CUKuSKmNSBN5WQVtR6_tNHrMlYfR8fq_Peh3E__TJS_Q68JSneddKDVtaKbM4fpOgCp-WVIvVOvCfcgZ1aBW4mJO-PAC2NfV9J-m5vUoOPo-Ha_ct_Gn0AW2dHQ_X5ZPzpFTyo96J9wOIubCzmJe7B_Stb7lcG8hsaUBAd |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+pyruvate+on+economy+of+contraction+in+isolated+rabbit+myocardium&rft.jtitle=European+journal+of+heart+failure&rft.au=Keweloh%2C+Boris&rft.au=Janssen%2C+Paul+M.L.&rft.au=Siegel%2C+Ulf&rft.au=Datz%2C+Nicolin&rft.date=2007-08-01&rft.issn=1388-9842&rft.eissn=1879-0844&rft.volume=9&rft.issue=8&rft.spage=754&rft.epage=761&rft_id=info:doi/10.1016%2Fj.ejheart.2007.03.011&rft.externalDBID=10.1016%252Fj.ejheart.2007.03.011&rft.externalDocID=EJHF2007-03-011 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-9842&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-9842&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-9842&client=summon |